Strategic therapeutic areas
Our in-house capabilities are focused on critical and differentiating areas such as target identification, with a strong emphasis on human and clinical validation, as well as translational science and disease understanding. Above and beyond these particularly critical success factors, we can cover every step in the development of an innovative medicine.
At the same time, we are committed to entering into strategic partnerships with innovative players from across industry and academia who share our passion for shaping the field and fostering the development of meaningful therapies. And alongside our pursuit of these four key areas, we are also looking for partners who are eager to team up with us in the development of therapeutic solutions for patients with fibromyalgia, complex regional pain syndrome, migraine and peri-surgical pain.